Storys aus Germany

Filtern
  • 28.08.2020 – 12:00

    HARTING Stiftung & Co. KG

    HARTING Technology Group has been shaping the future for 75 years

    Espelkamp, Germany (ots/PRNewswire) - Innovative products and solutions for Industry 4.0 For 75 years now, the HARTING Technology Group has been driving technological change. The vision formulated in 1996 by the owner family "We want to shape the future with technologies for people" remains the guiding star of our entrepreneurial activities. September 1 marks the 75th anniversary of the founding day of the family company. ...

  • 13.07.2020 – 20:03

    Merck Healthcare Germany

    Stephan Sieber Awarded EUR 1 Million Future Insight Prize 2020 by Merck

    Darmstadt, Germany (ots/PRNewswire) - - Prof. Sieber is developing approaches against multi-resistant pathogens at the Technical University of Munich - Inaugural Johann Anton Merck Award presented to Prof. Caroline Dive, Cancer Research UK, for her liquid biopsy research - Sibel Health awarded the Nature Spinoff Prize Merck, a leading science and technology company, ...

  • 03.07.2020 – 08:30

    CSL Behring

    IDELVION® Becomes First and Only Factor IX Therapy with 21-Day Prophylactic Dosing

    Hattersheim, Germany (ots/PRNewswire) - European Medicines Agency Approves 21-Day Dosing Intervals for Adult Haemophilia B Patients Global biotherapeutics leader CSL Behring announced today that the European Medicines Agency (EMA) has approved the new Summary of Product Characteristics, which includes information about new, extended dosing options for IDELVION® ...

  • 23.06.2020 – 15:58

    IgNova GmbH

    IgNova files patent application on antibody against COVID-19

    Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...